Endometrial cancer: asymptomatic endometrial findings. Characteristics of postmenopausal endometrial cancer

Endometrial cancer affects patients at every age, however it occurs more frequently in menopause (> 50) and in postmenopause (> 70). The most frequent symptoms are bleeding and vaginal discharge. When hematometra or pyometra is present the patient may feel pain. In some cases endometrial adenocarcinoma is asymptomatic and the diagnosis is casually made during ultrasound examination or by histological examination of a uterus surgically removed for other indications. In these cases the most frequent findings are polyps and abnormally increased thickness of the endometrial mucosa. In postmenopause polyps and abnormal endometrial thickness are usually limited to a small area and surrounded by atrophic mucosa. Higher incidence rates of endometrial cancer were correlated with polyps and an increased number of serous type tumors were identified in the > 65-year age group. Endometrial carcinoma may be estrogen correlated or non-estrogen associated. Patients in postmenopause are often affected by non-estrogen correlated endometrial carcinoma. According to Kurman and other authors the first type of endometrial adenocarcinoma (estrogen correlated) is characterized by low-grade malignancy. On the contrary, non-estrogen correlated neoplasia is more aggressive. In our case series including 102 women aged > 70 years with endometrial carcinoma we found that survival was correlated with stage and grading - early stages were the most frequent and the grade increased with stage. In fact all the patients with relapses had grade 2 or 3 adenocarcinomas. Thirty-one patients > 70 years (30.69%) had a non-endometrioid type of cancer.

Endometrial cancer; Elderly patients; Asymptomatic findings

[1] World Cancer Research Fund: American Institute for Cancer Research: Food, Nutrition and the Prevention of Cancer: A Global Perspective Washington, DC, 1997.

[2] Muensted K., Grant P., Woenckhaus J., Roth G., Tinneberg H.R.: "Cancer of the endometrium: current aspects of diagnostics and treatment" World J. Surg. Oncol., 2004, 2, 24.

[3] Watson P., Vasen H.F., Mecklin J.P., Jarvinen H., Lynch H.T.: "The risk of endometrial carcinoma in hereditary nonpolyposis colorectal cancer" Am. J. Med., 1994, 96, 516.

[4] Kaas R., Lukanova A., Kurzer M.S.: "Obesity, endogeneous hormones and endometrial cancer risk: a synthetic review". Cancer Epidemiol Biomarkers Prev., 2002, 11, 1531.

[5] Parazzini F., Negri E., La Vecchia C., Benzi G. et al.: "Role of reproductive factors on the risk of endometrial cancer". Int. J. Cancer, I 998, 76, 784.

[6] Hinkula M., Pukkala E., Kyyronen P., Kauppila A.: "Grand multiparity and incidence of endometrial cancer: a polpulation-based study in Finland". Int. J. Cancer, 2002, 8, 912.

[7] Fornander T., Rutqvist L.E., Cedermark B. et al.: "Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancer". Lancet, 1989, I, 117.

[8] Yamazawa K., Matsui H., Seki K., Sekiya S.: "A case-control study of endometrial cancer after antipsychotic exposure in premenopausal women". Oncology, 2003, 64, 116.

[9] Kurman R.J., Kaminski P.F., Norris H.J.:'The behaviour of endometrial hyperplasia: a long term study of'untreated' hyperplasia in 170 patients". Cancer, 1985, 56, 403.

[10] Sherman M.E.: "Theories of endometrial carcinogenesis: a multidisciplinary approach". Mod. Pathol., 2000, 13, 295.

[11] Robertson G.: "Screening for endometrial cancer". Am. Med. J., 2003, 178, 657.

[12] Gerber B., Krause A., Muller H.: "Ultrasonographic detection of asymptomatic endometrial cancer in postmenopausal patients offers no prognostic advantage over symptomatic disease discovered by uterine bleeding". Eur. J. Cancer, 2001, 37, 64.

[13] Langer R.D., Pierce J.J., O'Hanlan K.A.:'Transvaginal ultrasonography compared with endometrial biopsy for the detection of endometrial disease: Postmenopausal Estrogen/Progestin Interventions Trial". N. Engl. J. Med., 1997, 337, 1792.

[14] Marello F., Bettocchi S., Greco P., Ceci 0., Vimercati A., Di Venere R., Loverro G.: "Hysteroscopic evaluation of menopausal patients with sonographically atrophic endometrium". J. Am. Assoc. Gynecol. Laparosc., 2000, 7, 197.

[15] Litta P., Merlin F., Saccardi C., Pozzan C., Sacco G., Fracas M. et al.: "Role of hysteroscopy with endometrial biopsy to rule out endometrial cancer in postmenopausal women with abnormal uterine bleeding". Maturi/as, 2005, 14, 50, 117.

[16] Ng A.B.P., Reagan J.W., Hawliczek C.T., Wentz B.W.: "Significance of endometrial cells in the detection of endometrial carcinoma and its precursors". Acta Cytol., 1974, 18, 356.

[17] DuBeshter B., Deuel C., Gillis S., Glantz C., Angel C., Guzick D.: "Endometrial cancer: the potential role of cervical cytology in current surgical staging". Obstet. Gynecol., 2003, 101, 445.

[18] Schorge J.O., Hossein Saboorian M., Hynan L., Ashfaq R.:'Thin prep detection of cervical and endometrial adenocarcinoma: a retrospective cohort study". Cancer, 2002, 96, 338.

[19] Anastasiadis P.G., Kpoutlaki N.G., Skaphida P.G. et al.: "Endometrial polyps: prevalence, detectin and malignant potential in women with abnormal uterine bleeding". Eur. J. Gynaecol. Oncol., 2000, 21, 180.

[20] Reslova T., Tosner J., Resl M., Kugler R., Vavrova I.: "Endometrial polyps. A clinical study of 245 cases". Arch. Gynecol. Obst et., 1999, 262, 133

[21] Martin-Ondarza C., Gil-Moreno A., Torres-Cuesta L., Garcia A. et al.: "Endometrial cancer in polyps: a clinical study of 27 cases". Eur. J Gynaecol. Oncol., 2005, 26, 55.

[22] Hileeto D., Fadare O., Martel M., Zheng W.: "Age dependent association of endometrial polyps with increased risk of cancer involvement". World J. Surg. Oncol., 2005, 9, 3, 8.

[23] Petterson B., Adami H.O., Lindgren A., Hesselius I.: "Endometrial polyps and hyperplasia as risk factors for endomemtrial carcinoma. A casecontrol study of currettage specimen". Acta Obstet. Gynecol. Scand., 1985, 64, 653.

[24] Sherman M.D., Mazur M.T., Kurman R.J.: "Benign disease of the endometrium". In: Kurman R.J. ed. "Blaustein's Pathology of the Female Genital Tract", 5'" ed., New York, Springer, 2002, 421.

[25] Wheeler D.T., Bell K.A., Kurman R.J., Sherman M.E.: "Minimal uterine serous carcinoma: diagnosis and clinico pathologic correlation". Am J. Surg. Pathol., 2000, 24, 797.

[26] Silva E.G., Jenkins R.: "Serous carcinoma in endomemtrial polyps". Mod. Pathol., 1990, 3, 120.

[27] Maia H., Maltez A., Athayde C., Coutinho E.M.: "Proliferation profile of endometrial polyps in postmenopausal women". Maturitas, 2001, 40, 273.

[28] Taylor L.J., Jackson T.L., Reid J.G., Duffy S.R.:'The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki67 in endometrial polyps". Br. J. Oncol. Gynaecol., 2003, 110, 794.

[29] Mourits M.J.,D e Vries E.G.,W illemse P.H.,T en Hoor K.A.,H ollema V.,V an der Zee A.G.: "Tamoxifen treatment and gynecologic side effects a review". Obstet. Gynecol., 2001, 97, 855.

[30] Neven P., Vergote I.: "Tamoxifen, screening and new oestrogen receptor modulatore". Best Pract. Res. Clin. Obstet. Gynecol., 2001, 15, 365.

[31] Eltabbakh Gh., Mount S.L.:'Tamoxifen and the female reproductive tract". Exp. Opin. Pharmacother., 2001, 2, 1399.

[32] Swerdlow A.J., Jones M.E.: "British Tamoxifen Second Cancer Study Group, Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study". J. Natl. Cancer Inst., 2005, 97, 375.

[33] Burkhart C., Wight E., Pok J., Kernen B., Traber M., Haller U., Bajka M.: "Ultrasound endometrium follow-up during tarnoxifen treatment: really not reliable or useful after all?". Ultraschall Med., 2001, 22, 136.

[34] Gerber B., Krause A., Muller H., Reimer T., Kulz T., Makovitzky J. et al.: "Effects of adjuvant tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound". J. Clin. Oneal., 2000, 18, 3464.

[35] Liedman R., Lindahl B., Andolf E., Willen R., Ingvar C., Ranstam J.: "Discordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with tamoxifen". Anticancer Res., 2000, 20, 4889.

[36] Cohen I., Bernheim J., Azaria R., Tepper R., Sharony R., Beyth Y.: "Malignant endometrial polyps in postrnenopausal breast cancer tamoxifentreated patients". Gynecol. Oncol., 1999, 75, 136.

[37] Le Bouedec G., Penault-Llorca F., de Latour M., Tortochaux J., Dauplat J.: "Mixed mullerian tumors of the endometrium. About four cases developed on tarnoxifen treatment". Gynecol. Obstet. Fertil., 2003, 31, 733.

[38] Moe M.M., El-Sharkawi S.: "Is there any association between uterine malignant !nixed mullerian tumour, breast cancer and prolonged tamoxifen treatment?". J. Obstet. Gynecol., 2003, 23, 301.

[39] Deligdisch L., Kalir T., Cohen C.J., De Latour M., Le Boudec G., Penault-Llorca F.: "Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer". Gynecol. Oncol., 2000, 78, 181.

[40] Varras M., Akrivis C.H.: "Large endometrial polyp with sarcomatous stromal components following long-term tamoxifen treatment for breast cancer: a case report and review of the literature". Eur. J. Gyneacol. Oncol., 2003, 24, 565.

[41] Bergman L., Beelen M.L.R., Gelmann E.P.: "Risk and prognosis of endometrial cancer after tamoxifen for breast cancer". Lancet, 2000, 356, 881.

[42] Ciatto S., Cechini S., Gervasi G., Landini A. et al.: "Surveillance for endometrial cancer with transvaginal ultrasonography of breast cancer patients under tamoxifen treatment". Br. J. Cancer, 2003, 88, 1178.

[43] Renard F., Vosse M., Scagnol 1., Verhest A.: "Aggressive endometrial carcinoma in a breast cancer patient treated with tamoxifen with normal transvaginal ultrasonography. Case report". Eur. J. Gynecol. Oncol., 2002, 23.

[44] Machado F., Rodriguez J.R., Leon J.P.H., Parrilla J.J., Abad L.: "Tarnoxifen and endometrial cancer: is screening necessary? A review of the literature". Eur. J. Gynaecol. Oncol., 2005, 3, 257.

[45] Hecht J.L., Ince T.A., Baak J.P., Baker H.E., Ogden M.W., Mutter G.L.: "Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis". Mod. Pathol., 2005, 18, 324.

[46] Onnis A.: "Clinical experience in gynecological management: a) Endomemtrial cancer: repert from the Gynecologic Institutes of Padua University (1963-1989)". Eur. J. Gyneacol. Oncol., 1990, 11, 1.

[47] Bellino R., Arisio R., D'Addato F., Alba E. et al.: "Pathologic features of endometrial carcinoma in elderly women". Anticancer Res., 2001, 21, 3721.

[48] Jobo T., Arai T., Sato R., Kuramoto H.: "Clinicopathologic relevance of asymptomatic endometrial carcinoma". Acta Cytol., 2003, 47, 611.